Hi, what are you looking for?
By Denny Jacob
Metagenomi Technologies filed for an initial public offering.
The precision genetics medicines company didn’t provide details on how many shares it was planning to offer or where it expects to price those shares.
Metagenomi applied to list its common stock on the Nasdaq Global Select Market under the ticker MGX.
Write to Denny Jacob at [email protected]
Read the full article here
This article was written by Follow I specialize in constructing investment portfolios aimed at generating additional income through dividends. My focus lies on identifying...
This article was written by Follow I am a full-time analyst interested in a wide range of stocks. With my unique insights and knowledge,...
This article was written by Follow The Investment Doctor is a financial writer, highlighting European small-caps with a 5-7 year investment horizon. He strongly...
Listen below or on the go on Apple Podcasts and Spotify Nonfarm payrolls are seen up 200K for November. (0:18) Salesforce leads the smaller...
